Uveitis clinical trials at University of California Health
4 in progress, 2 open to eligible people
Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
open to eligible people ages 18-75
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
at UCLA
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
open to eligible people ages 18 years and up
This is a multi-center randomized controlled evaluator-masked trial designed to compare metagenomic deep sequencing (MDS) versus standard of care testing for improvement of outcomes for intraocular infections. Patients with presumed intraocular…
at UC Davis UCLA UCSF
Mindfulness Approach for Reducing Anxiety and Gloom in Ocular Inflammatory Diseases
Sorry, in progress, not accepting new patients
The proposed study is a block-randomized, controlled trial to evaluate the effects of a digital meditation and mindfulness practice on mental health in patients with non-infectious uveitis.
at UCSF
OCS-01 in Subjects With Uveitis Related and Post Surgical Macular Edema
Sorry, in progress, not accepting new patients
The goal of the LEOPARD clinical trial is to investigate a new kind of steroid eye drops, OCS-01. Macular edema is a condition in which there is collection of fluid (edema) in the back of the eye (Macula) and it can lead to severe loss of vision.…
at UCLA
Our lead scientists for Uveitis research studies include Nisha Acharya, MD, MS Thuy Doan, MD, PhD Edmund Tsui, MD.
Last updated: